Martin Babler, President, CEO at Principia Biopharma Inc. (PRNB), sold 25,000 shares at $53.94 ($1.3M) on 2019-12-17, disclosed to the SEC on 2019-12-19.
Open-market sale of $1.3M PRNB by President, CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.80 | 5,840 | $303K | 22.8% |
| 2 | $52.86 | 11,485 | $607K | 45.9% |
| 3 | $53.94 | 6,661 | $359K | 27.1% |
| 4 | $54.36 | 1,014 | $55K | 4.2% |
| Total | $52.96 avg | 25,000 | $1.3M | 100% |
| Filing → |
| PRNB | SELL | 2020-03-05 | $1.9M | — | Filing → |
| PRNB | SELL | 2019-12-19 | $2.8M | — | Filing → |
| PRNB | SELL | 2019-12-19 | $965K | — | Filing → |